T-LAB

The Golden Era of PRP Technology 💫

T-LAB's experience and D-MED's vision 🔥

D-MED PRP Tubes 🧪

D-MED PRP Syringe 💉

D-MED PRP Kit 🩸

Contact us for detailed information.
+90 224 234 3633

IMCAS World Congress 2026 | Paris 🇫🇷

Timur Veysel Doğruok, Founder & CEO of D-MED & T-LAB, took part as a speaker in three different sessions at IMCAS World Congress 2026, one of the world’s most prestigious medical aesthetics congresses, held under the moderation of internationally recognized experts in the field.

Sharing the same scientific platform with distinguished names such as Prof. Guy Magalon, Prof. Jeremy Magalon, Dr. Patrick Po-Han Huang, Dr. John Cole, and Dr. Ryan Welter,
comprehensive presentations and panels were delivered, covering PRP, autologous regenerative approaches, product analysis, and clinical applications.

We are proud to contribute to global scientific exchange by sharing science, innovation, and clinical expertise on an international stage.


IMCAS World Congress 2026 | Paris 🇫🇷

D-MED & T-LAB Kurucu ve CEO’su Timur Veysel Doğruok, dünyanın en prestijli medikal estetik kongrelerinden IMCAS 2026’da, alanında uluslararası otorite kabul edilen hekimlerin başkanlığını yaptığı 3 ayrı session’da konuşmacı olarak yer aldı.

Prof. Guy Magalon, Prof. Jeremy Magalon, Dr. Patrick Po-Han Huang, Dr. John Cole ve Dr. Ryan Welter gibi önemli isimlerle aynı bilimsel platformda;
PRP ve otolog rejeneratif yaklaşımlardan ürün analizine ve klinik uygulamalara uzanan kapsamlı sunumlar ve paneller gerçekleştirildi.

Bilimi, inovasyonu ve klinik deneyimi küresel ölçekte paylaşmanın gururunu yaşıyoruz.

Timur Veysel Doğruok, Founder and CEO of D-MED & T-LAB, delivered an outstanding opening speech to over 150 physicians and distributors at the D-MED & T-LAB Gala Dinner on the first day of the IMCAS Congress.

We would like to thank everyone who joined us for the evening.


D-MED & T-LAB Kurucu ve CEO’su Timur Veysel Doğruok, IMCAS Kongresi’nin ilk günü D-MED & T-LAB Gala Yemeği’nde 150’den fazla hekim ve distribütöre harika bir açılış konuşması yaptı.

Gecede bizlerle olan herkese teşekkür ediyoruz.

Proud Moments at IMCAS Congress for D-MED & T-LAB🔥

Some highlights from today at the IMCAS World Congress 2026.

IMCAS World Congress 2026 | Paris

The IMCAS World Congress 2026 brings together global experts in aesthetic medicine and regenerative science for an extensive scientific program in Paris.

On January 29–31, 2026, Timur Veysel Doğruok, Founder of D-MED and T-LAB, will take part in multiple sessions addressing regenerative therapies, product analysis, and non-surgical clinical approaches.

Sessions include:
📌 PRP in Collaboration with Cyasia
Focus Session — multidisciplinary perspectives on PRP applications
📌Product Analysis: From Nanofat to Mechanical Stromal Vascular Fraction for Regenerative Medicine
Product Analysis — scientific and technical evaluation of regenerative products
📌Actionable Hair Playbook: AGA, CA & AA – No Scalpel Required
Focus Session — contemporary, non-surgical hair treatment protocols

During these sessions, D-MED & T-LAB contribute to the scientific collaboration shaping current and future practices in regenerative medicine at IMCAS 2026.

IMCAS World Congress 2026 | Paris

The IMCAS World Congress 2026 brings together global experts in aesthetic medicine and regenerative science for an extensive scientific program in Paris.

On January 29–31, 2026, Timur Veysel Doğruok, Founder of D-MED and T-LAB, will take part in multiple sessions addressing regenerative therapies, product analysis, and non-surgical clinical approaches.

Sessions include:
📌 PRP in Collaboration with Cyasia
Focus Session — multidisciplinary perspectives on PRP applications
📌Product Analysis: From Nanofat to Mechanical Stromal Vascular Fraction for Regenerative Medicine
Product Analysis — scientific and technical evaluation of regenerative products
📌Actionable Hair Playbook: AGA, CA & AA – No Scalpel Required
Focus Session — contemporary, non-surgical hair treatment protocols

During these sessions, D-MED & T-LAB contribute to the scientific collaboration shaping current and future practices in regenerative medicine at IMCAS 2026.